GlutathioneCheck methods and identity
What the October 2026 recall tells us about product quality
2 numbered sourcesSource years 2019, 2026
Peptide bonds link amino acids into short chains called peptides. Some help cells manage chemical stress. Glutathione is a naturally occurring peptide made of three amino acids that participates in those protective reactions. A recall posted by the FDA in October 2026 concerned a different question, whether certain compounded glutathione products met a safety standard for bacterial endotoxins. [1]
The company announced a voluntary recall of specific lots after identifying potential elevated endotoxin levels. Endotoxins are components of certain bacteria that can provoke an immune response. The announcement also reported two patients who received emergency department care after receiving a glutathione product in a manner for which it was not formulated. The notice describes the reported events and the quality concern. The reports alone cannot determine the frequency of such events across other products or establish every cause. [1]
An older FDA alert in 2019 described a separate investigation involving compounded glutathione products. In that case, the agency tested the underlying material and confirmed excessive endotoxin levels relative to the exposure involved. The two records concern different products and dates. They both illustrate why the properties of an active molecule and the quality of a finished preparation are separate questions. [1] [2]
The fact that cells naturally make glutathione helps explain its biological importance. It does not establish the quality of a prepared product or address which impurities may be present. A dated recall notice documents a specific quality issue, while studies of the peptide's role in cells address a different kind of evidence. [1] [2]
Sources
Original works cited in this article. Links open the external record in a new tab.
